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This represents yet another carefully written report from the
data collected by the Vascular Study Group of Northern New
England (VSGNNE). They have begun the arduous and necessary
task of correlating preoperative risk factor assessment with postop-
erative outcome data, to help guide vascular surgeons in their
choice of therapy for patients with vascular disease. To date, they
have reported outcomes of carotid therapies and several aspects of
lower extremity revascularization.
Rather than using traditional 30-day mortality, the authors
acknowledge that recovery from intervention often spans several
weeks to months, and from a patient perspective one-year out-
comes have more relevance. This report serves two primary goals –
establishing preoperative predictors of success, and developing
benchmarks for hospitals, and eventually individual surgeons, to
identify practices and procedures that could be adopted or modi-The first goal leads them to their most controversial sugges-
tion: “Therefore, successful surgeons must select for operation
only those patients who will live for at least a year after surgery, and
only those patients who will not suffer amputation or graft occlu-
sion within the first year after their bypass.” As we encounter
increasingly aged and ill patients, quality of life as well as longevity
becomes a critical factor. Many patients, if afforded the option,
would prefer limb salvage to amputation if the recovery and rehab
times were similar. Perhaps if the authors were able to incorporate
their previously published risk factors for predicting independent
ambulation (age, preoperative ambulatory ability, independent living
status, critical limb ischemia) into their model, a combined quality/
quantity of life estimate could be reached. They acknowledge the
difficulty of this, but it is certainly a worthy long term goal.
The second goal of this study and of the VSGNNE is timely
and prescient. As Congress and the Administration wrestle with
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tiveness Research Institute, it is critical that vascular surgeons take
the lead in establishing outcomes models, or else they will be
provided by other specialty or governmental groups. Which spe-
cialty is better equipped to develop outcomes models honestly and
without bias, as we provide comprehensive medical, interventional
and surgical care to our patients?
As with the National Surgical Quality Improvement Project,mance compared to established benchmarks is only the first step –
the true utility of these studies for individual surgeons and institu-
tions is to identify practices and procedures that could be adopted
or modified for improvements in care. As with many such studies,
despite a carefully constructed reporting system and the participa-
tion of multiple institutions, some questions remain unanswered
due to relatively small numbers and infrequent outcomes. Thus
one intriguing question remains – what factors lead to better thanidentification of institutions with both poor and superior perfor- expected outcomes at one center, and worse outcomes at another?
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